John W. LaRocca's most recent trade in Y-Mabs Therapeutics Inc was a trade of 42,900 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | John W. LaRocca | SVP, General Counsel & Secry | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 42,900 | 42,900 | - | - | Employee Stock Option (right to buy) | |
| Y-Mabs Therapeutics Inc | John W. LaRocca | SVP, General Counsel & Secry | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 21,500 | 21,500 (0%) | 0% | 0 | Common Stock |